80 related articles for article (PubMed ID: 30132548)
1. Immunohistochemical detection of E7 human papillomavirus protein in pre‑malignant and malignant lesions of the uterine cervix.
Shi L; Han F; Shi C; Huang Y; Liu Y; Chang X
Mol Med Rep; 2018 Oct; 18(4):3949-3956. PubMed ID: 30132548
[TBL] [Abstract][Full Text] [Related]
2. Expression of P16 in high-risk human papillomavirus related lesions of the uterine cervix in a government hospital, Malaysia.
Krishnappa P; Mohamad IB; Lin YJ; Barua A
Diagn Pathol; 2014 Nov; 9():202. PubMed ID: 25361681
[TBL] [Abstract][Full Text] [Related]
3. Expressions of E2 and E7-HPV16 proteins in pre-malignant and malignant lesions of the uterine cervix.
Ramirez N; Guerra F; Camporeale G; Quintana S; Diaz LB; Cuneo N; Villacorta Hidalgo J; Tatti SA; Alonso LG; Borkosky SS; Prat Gay G; Palaoro L
Biotech Histochem; 2015; 90(8):573-80. PubMed ID: 26052817
[TBL] [Abstract][Full Text] [Related]
4. High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma.
Ressler S; Scheiden R; Dreier K; Laich A; Müller-Holzner E; Pircher H; Morandell D; Stein I; Viertler HP; Santer FR; Widschwendter A; Even J; Jansen-Dürr P; Capesius C; Zwerschke W
Clin Cancer Res; 2007 Dec; 13(23):7067-72. PubMed ID: 18056184
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma.
Lie AK; Kristensen G
Expert Rev Mol Diagn; 2008 Jul; 8(4):405-15. PubMed ID: 18598223
[TBL] [Abstract][Full Text] [Related]
6. p16INK4A expression in cervical premalignant and malignant lesions.
Lambert AP; Anschau F; Schmitt VM
Exp Mol Pathol; 2006 Apr; 80(2):192-6. PubMed ID: 16257403
[TBL] [Abstract][Full Text] [Related]
7. Detection of HPV E7 oncoviral protein in cervical lesions by a new antibody.
Faoro V; Barbazza R; Bonin S; Brunetti D; Sulfaro S; Stanta G
Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):341-50. PubMed ID: 22935825
[TBL] [Abstract][Full Text] [Related]
8. Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker.
Fontecha N; Basaras M; Hernáez S; Andía D; Cisterna R
BMC Cancer; 2016 Nov; 16(1):852. PubMed ID: 27816058
[TBL] [Abstract][Full Text] [Related]
9. Vitamin A deficiency in K14E7HPV expressing transgenic mice facilitates the formation of malignant cervical lesions.
Ocadiz-Delgado R; Serafin-Higuera N; Alvarez-Rios E; García-Villa E; Tinajero-Rodríguez M; Rodríguez-Uribe G; Escobar-Wilches DC; Estela Albino-Sánchez M; Ramírez-Rosas A; Sierra-Santoyo A; Hernández-Pando R; Lambert P; Gariglio P
APMIS; 2021 Aug; 129(8):512-523. PubMed ID: 34046932
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical Evaluation of E6/E7 HPV Oncoproteins Staining in Cervical Cancer.
Stiasny A; Kuhn C; Mayr D; Alexiou C; Janko C; Wiest I; Jeschke U; Kost B
Anticancer Res; 2016 Jun; 36(6):3195-8. PubMed ID: 27272848
[TBL] [Abstract][Full Text] [Related]
11. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.
Hu D; Zhou J; Wang F; Shi H; Li Y; Li B
Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical overexpression of p16 protein associated with cervical cancer in Thailand.
Jedpiyawongse A; Homcha-em P; Karalak A; Srivatanakul P
Asian Pac J Cancer Prev; 2008; 9(4):625-30. PubMed ID: 19256750
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus (HPV) E6/E7 mRNA detection in cervical exfoliated cells: a potential triage for HPV-positive women.
Yao YL; Tian QF; Cheng B; Cheng YF; Ye J; Lu WG
J Zhejiang Univ Sci B; 2017 Mar.; 18(3):256-262. PubMed ID: 28271661
[TBL] [Abstract][Full Text] [Related]
14. HPV infection and p16
Missaoui N; Mestiri S; Bdioui A; Zahmoul T; Hamchi H; Mokni M; Hmissa S
Pathol Res Pract; 2018 Apr; 214(4):498-506. PubMed ID: 29572122
[TBL] [Abstract][Full Text] [Related]
15. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions.
Sano T; Oyama T; Kashiwabara K; Fukuda T; Nakajima T
Am J Pathol; 1998 Dec; 153(6):1741-8. PubMed ID: 9846965
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
[TBL] [Abstract][Full Text] [Related]
17. Human Papillomavirus E7 Oncoprotein Promotes Proliferation and Migration through the Transcription Factor E2F1 in Cervical Cancer Cells.
Tian S; Zhang L; Li Y; Cao D; Quan S; Guo Y; Yang X; Yang T
Anticancer Agents Med Chem; 2021; 21(13):1689-1696. PubMed ID: 33155930
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of level of expression of p16 (INK4a) in endocervical lesions of uterine cervix].
Popovska S; Betova T; Tomov S; Gorchev G; Dikov T
Akush Ginekol (Sofiia); 2005; 44(5):9-13. PubMed ID: 16313047
[TBL] [Abstract][Full Text] [Related]
19. [Human papillomavirus E7 oncoprotein and its role in the cell transformation].
Vallejo-Ruiz V; Velázquez-Márquez N; Sánchez-Alonso P; Santos-López G; Reyes-Leyva J
Rev Med Inst Mex Seguro Soc; 2015; 53 Suppl 2():S172-7. PubMed ID: 26462513
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of type-specific oncogenic human papillomavirus infection assessed by HPV E6/E7 mRNA among women with high-grade cervical lesions.
Wang HY; Park S; Lee D; Kim S; Kim G; Park KH; Lee H
Int J Infect Dis; 2015 Aug; 37():135-42. PubMed ID: 26141414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
